The DiagNoze device reads volatile organic compounds in exhaled air, identifying biomarkers for various conditions, including tuberculosis, offering quick and cost-effective health insights.
DiagNoze's compact design and ease of use make it a practical solution for healthcare settings with limited resources, enabling rapid diagnostics for improved patient outcomes.
With a significant boost from the Bill & Melinda Gates Foundation, DiagNoze aims to support a clinical study to detect TB in high-burden countries.
Noze envisions DiagNoze as part of everyday healthcare, where real-time health monitoring becomes routine, revolutionizing diagnostics toward a proactive healthcare model.
Collection
[
|
...
]